Innate Pharma IPHA Ratios (2017-2026)

NASDAQ IPHA
$1.57 -0.01 (-0.50%)
As of: Oct 21, 2026 · 9:35 AM EDT
Reported Financials

Innate Pharma Quarterly Ratios

Periods 16 quarters
Latest Jun 2026

Innate Pharma ratios data for the quarter ended Jun 2026. These financial ratios cover 16 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2017 Dec2018 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025 Jun2026
Efficiency
Assets AverageAssets Avg. 410.37M412.11M376.37M347.49M309.89M297.95M252.71M214.40M205.11M178.07M138.90M112.28M91.33M56.67M
Equity AverageEquity Avg. 146.98M238.62M212.76M175.41M140.32M121.60M89.63M60.31M60.17M44.14M20.01M7.61M-9.73M-35.88M
Invested CapitalInvested Cap. 109.25M195.00M262.30M252.84M213.52M182.90M137.70M135.43M102.17M103.18M92.38M59.69M32.67M28.55M-5.23M-33.60M
Leverage & Solvency
Debt Ratio 0.020.010.040.050.060.080.050.050.210.190.180.180.200.210.280.32
Valuation
Price to BookP/B 2.082.301.681.632.981.775.143.903.925.0616.7825.29
Enterprise Value 260.88M372.11M136.54M117.85M227.00M85.91M188.50M148.39M122.94M57.78M70.20M82.17M123.70M160.00M
Market Capitalization 506.06M538.28M323.05M259.87M362.71M214.77M296.69M244.99M225.27M156.08M154.25M152.57M164.01M172.44M

Innate Pharma Ratios API

Pull Innate Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IPHA&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY